# Cost-utility and Immuno-inflammatory Effects of the FIBROWALK in Patients With Fibromyalgia (the On&Out Study)

> **NCT05377567** · NA · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 225 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **BEHAVIORAL:** TAU + FIBRO-On
- **BEHAVIORAL:** TAU + FIBRO-Out
- **OTHER:** Treatment as Usual (TAU)

## Key facts

- **NCT ID:** NCT05377567
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-15
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05377567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05377567, "Cost-utility and Immuno-inflammatory Effects of the FIBROWALK in Patients With Fibromyalgia (the On&Out Study)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05377567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*